OptimizeRx Corp - FORM 10-K - EX-10.5 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH STEPHEN SILVESTRO, DATED MARCH, 10, 2020 - March 26, 2020

Attached files

file filename
10-K - ANNUAL REPORT - OptimizeRx Corpf10k2019_optimizerxcorp.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO - OptimizeRx Corpf10k2019ex32-1_optimizerx.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECURITIES EXCHANGE ACT RUL - OptimizeRx Corpf10k2019ex31-2_optimizerx.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECURITIES EXCHANGE ACT RUL - OptimizeRx Corpf10k2019ex31-1_optimizerx.htm
EX-23.1 - CONSENT OF MARCUM LLP - OptimizeRx Corpf10k2019ex23-1_optimizerx.htm
EX-21.1 - LIST OF SUBSIDIARIES - OptimizeRx Corpf10k2019ex21-1_optimizerx.htm
EX-10.6 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH MIRIAM PARAMORE, DATED MARCH, 10, 2020 - OptimizeRx Corpf10k2019ex10-6_optimizerx.htm
EX-10.4 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH WILLIAM FEBBO, DATED MARCH, 10, 2020 - OptimizeRx Corpf10k2019ex10-4_optimizerx.htm
EX-10.3 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH DOUG BAKER, DATED MARCH 10, 2020 - OptimizeRx Corpf10k2019ex10-3_optimizerx.htm

Exhibit 10.5

 

Employment Agreement Addendum I

Addendum to agreement dated March 18, 2019

 

This first addendum to the employment agreement (the “Addendum”) is made this 10th day of March 2020, by and between OptimizeRx, Corporation (the “Company”), a Nevada Company, and Stephen Silvestro (the “Executive”).

 

Base Salary: The Executive will receive a base salary at the annualized rate of $300,000.00 (“Base Salary”), which will be paid in accordance with normal Company payroll practices and subject to the usual and applicable required withholding(s).

 

Bonus: The Executive will be eligible to participate in the Company’s Executive Bonus Plan, subject to terms and conditions, with an annual target bonus of 50% of base salary.

 

Effective Date: January 1, 2020

 

Acknowledgment:

 

Except as expressly set forth herein, all other terms of the Agreement remain in full force and effect.

 

OptimizeRx, Corporation  Stephen Silvestro
    
By: William Febbo  By: Stephen Silvestro
Its: Chief Executive Officer  Date: March 10, 2020
Date: March 10, 2020   

 

Stock widget

Investing forum

OptimizeRx Corp Reports